The following is intended to share some of the work that we have done in the field of medicine and digital health. This page includes information about our portfolio companies as well as interesting digital-health relevant content provided by our team.
BeeKeeperAI Raises $12.1M in Series A Funding
June 28, 2023
BeeKeeperAI, a San Francisco, CA-based provider of zero-trust, collaboration software for the development and deployment of artificial intelligence (AI), raised $12.1M in Series A funding.
The round was led by Sante Ventures, with participation from Continuum Health Ventures, the Icahn School of Medicine at Mount Sinai, AIX Ventures, TA Group Holdings, and UCSF.
BeekeeperAI also announced announced the general availability of EscrowAI, a patent-protectedi zero-trust collaboration platform. EscrowAI leverages Azure confidential computing to resolve the challenges of data sovereignty, privacy, and security. In healthcare, EscrowAI enables HIPAA-compliant research on full PHI without exposing the patient data, thereby reducing the AI development timeline dramatically due to streamlined collaboration agreements and access to more precise data.
DeepWell DTx's founder launches Medicinal Media, highlights links between games and healing
May 5, 2023
Sanctuary AI rolls out Phoenix, a Carbon-based humanoid AI labor robot
May 5, 2023
Sanctuary AI has revealed a new humanoid robot, shooting for the "world's first human-like intelligence in general purpose robots (GPR). The first commercially available, general-purpose robot of its kind: a 5-foot, 7-inch working machine named Phoenix, is powered by an advanced AI software system called Carbon.
Phoenix features dexterous hands intended to perform tasks ranging from stocking shelves to unloading a truck to working a register to many healthcare applications.
Biotia a CHV portfolio raises U$8M Series A
Aug 23, 2022
Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures. OCA, a veteran early stage venture firm operating from Chicago and Palo Alto was joined by other key investors including Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others. Prior Seed round investors include Falcon II Ventures, Tau Ventures, Hyperplane Venture Capital, Leawood Venture Capital, SpringTide Ventures, and others.
Immunis a CHV portfolio raises U$10M Series A
Aug 3, 2022
Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series A First Closing financing led by Remiges Ventures with participation by several other healthcare investment firms. Strategic investor, Continuum Health Ventures, which supports thesis-driven startups at the intersection of health and technology in the digital health and longevity sectors, also joined the round. Proceeds will support clinical assessment of Immunis’ immunomodulatory secretome product in an FDA-awarded Phase 1/2a clinical trial targeting muscle atrophy, which is an age, disuse and disease-associated condition experienced by 100% of the population.
Enara Health a CHV portfolio raises U$6M Seed
June 27, 2022
Enara Health, the holistic weight management platform that is building a healthcare network to scale medical obesity treatment announced today $6M in seed funding led by Offline.VC and with Charge.VC, Crossover.VC, ContinuumHealth.VC, VSC Ventures, and notable angels including Raj Kapoor, Kevin Mahaffey, and Matt Brezina. Combined, these investors bring experience in top companies such as Tonal, Lyft, ClassPass, and FitMob. The funds will be used to scale Enara's medical obesity treatment and expand its current network of 30 healthcare providers and specialists.
Sanctuary.AI a CHV portfolio raises U$58.5M Series A
March 02, 2022
Sanctuary Cognitive Systems Closes C$75.5 Million (US$58.5 Million) Series A Funding, Accelerating its Mission to Create the World’s First Human-Like Intelligence in General-Purpose Robots to Address Labour Shortages Around the World
Supervised by people, Sanctuary general-purpose robots will improve the nature of work and strengthen the global economy.
Vancouver, Canada – March 2, 2022, Sanctuary Cognitive Systems Corporation, a company focused on creating the world’s first human-like intelligence in general-purpose robots, today announced the successful closing of an oversubscribed C$75.5 million (US$58.5 million) Series A funding.
New video game company aims to develop therapeutic games
March 15, 2022
Video game-based tools can help with conditions like depression and ADHD, research shows. DeepWell Digital Therapeutics plans to build on those studies. “There was an amazing amount of science that had already been done,” Douglas says. “We started to recognize exactly how therapeutic these games already were.”
2021: A Year of Transformation
Dr. Daniel Kraft
In this address, Dr. Daniel Kraft revisits his discussions with the health care industry’s leading voices on topics that range from sickle cell disease (redefining the red blood cell) to the data supply chain to preeclampsia and ‘physician culture.’ Daniel also takes a long look forward at the ways health care will continue to evolve as an industry in 2022, creating a system that’s more proactive, equitable, and collaborative. We learned a lot from our guests on Healthy Conversations last year, thank you to all of our guests and a very special thank you to all health care professionals who work so hard to care for us all.
The Future of Health & Medicine: Looking Ten Years Back & Ten Forward...
Dr. Daniel Kraft
In this blog post, Dr. Daniel Kraft breaks down the past, present, and future of digital health. This blog post has bee viewed hundreds of thousands of times and follows the arc of predictions that Dr. Kraft made 10 years related to digital health. He then reflects on where we are 10 years later, and also makes predictions on where we may be a decade from now. A must read for anyone interested in digital health.
How COVID-19 transformed the future of medicine
Dr. Daniel Kraft
The pandemic forced the world to work together like never before and, with unprecedented speed, bore a new age of health and medical innovation. Physician-scientist Daniel Kraft explains how breakthroughs and advancements like AI-infused antiviral discoveries and laboratory-level diagnostic tools accessible via smartphones are paving the way for a more democratized, connected and data-driven future of medicine and personalized care.
Interview with Dr. Daniel Kraft. Medicine of the Future: How Technologies Are Changing Healthcare
Dr. Daniel Kraft
In this interview with Sergey Avdeychik, Dr. Kraft breaks down how he sees digital technologies transforming the future of healthcare. His insights discuss smart household items in healthcare, areas of application of intelligent systems, scalability and efficiency of 3D printing, evolution and threats of AI application, and even some implications on how blockchain can impact the future of data in healthcare. Early in the interview, he also shares whether AI will come to replace human doctors.
The answer to Medical Misinformation on Social Media might be More Information
Prerak Juthani has an interest in utilizing technology to fight misinformation. He has published multiple op-eds on this topics and even done qualitative research studies on the topic. In fact, in 2020, he published a qualitative study in which he documented how he used the social media application "TikTok" to combat misinformation early during the COVID-19 pandemic. This abstract, titled: "Utilizing Social Media as a Means of Spreading Credible Information Regarding the Coronavirus Disease 2019 (COVID-19) Pandemic" was a winner of the 2020 American Medical Association Impact Challenge.
Understanding COVID-19 from a Research Perspective and Where We're Headed from Here
Given the state of the world, we think it is only fair to ensure we acknowledge the profound impact COVID-19 has had on everyone. With that being said, we also believe that the medical understanding and revelations related to COVID-19 will continue to shape the future of digital health and healthcare more broadly. Prerak has done quite a bit of work in the realm of understanding clinical outcomes related to COVID-19 and has authored multiple studies on the topic. Having these insights will lend a medical perspective to what the future can realistically look like. Feel free to refer to the studies by clicking on them directly on the right.